French pharma major Sanofi's participation at the JP Morgan Healthcare Conference was marked by a comprehensive overview of its position in 2024 and its strategic vision for the future.

The new headquarters from Belfast-based Diaceutics are in close proximity to the majority of its life science customers in ...

Barclays analyst Matt Miksic maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) today and set a price target of $160.00.

AbbVie closed out the year on a high note, as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s ...

Robert F. Kennedy Jr. has reportedly secured the votes needed for confirmation as Secretary of Health and Human Services (HHS).

Allan Coukell, chief government affairs officer at Civica, said manufacturing has begun at the company's new pharmaceutical plant in Virginia but there is no timeline for when the first insulin -- a ...

Sinclair joins VCCP from Grey Health and Wellness, where she served as president for just over four years. Creative agency ...

Vicks once again achieved the top monthly spot for TV impressions, while iSpot noted that pharma brands generated more year-over-year returns from sports and news cables compared to 2023.

American healthcare and pharma sector. A final factor worth keeping track of is the Corporate Sustainability Reporting Directive.

Dr. Alexandra Sowa joins 'Varney & Co.' to discuss weight-loss drugs becoming widely available and RFK Jr.'s push to ban ...

The Supreme Court was also told that Ramdev was not cooperating in proceedings before the trial court and hadn’t appeared on ...

Leerink Partners analyst Marc Goodman has maintained their bullish stance on JNJ stock, giving a Buy rating on January 8.Stay Ahead of the ...